These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2836547)

  • 1. Protective effects of monoclonal antibodies against parainfluenza virus type 3-induced brain infection in hamsters.
    Rydbeck R; Löve A; Norrby E
    J Gen Virol; 1988 May; 69 ( Pt 5)():1019-24. PubMed ID: 2836547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response.
    Ray R; Glaze BJ; Compans RW
    J Virol; 1988 Mar; 62(3):783-7. PubMed ID: 2828674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
    Orvell C; Rydbeck R; Löve A
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus.
    van Wyke Coelingh KL; Winter CC; Tierney EL; Hall SL; London WT; Kim HW; Chanock RM; Murphy BR
    J Virol; 1990 Aug; 64(8):3833-43. PubMed ID: 1695256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parainfluenza virus type 2 haemagglutinin-neuraminidase glycoprotein characterized with monoclonal antibodies.
    Rydbeck R; Löve A; Orvell C
    J Gen Virol; 1988 Apr; 69 ( Pt 4)():931-5. PubMed ID: 2451708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of four parainfluenza virus type 3 proteins by use of monoclonal antibodies.
    Rydbeck R; Orvell C; Löve A; Norrby E
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1531-42. PubMed ID: 2426392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies.
    Tsurudome M; Nishio M; Komada H; Bando H; Ito Y
    Virology; 1989 Jul; 171(1):38-48. PubMed ID: 2545038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoproteins of human parainfluenza virus type 3: affinity purification, antigenic characterization and reconstitution into lipid vesicles.
    Ray R; Compans RW
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():409-18. PubMed ID: 3029283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity.
    Garg R; Brownlie R; Latimer L; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
    Vaccine; 2017 Dec; 35(51):7139-7146. PubMed ID: 29153777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies against the glycoproteins of mumps virus: fusion inhibition by anti-HN monoclonal antibody.
    Tsurudome M; Yamada A; Hishiyama M; Ito Y
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2259-65. PubMed ID: 3760826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic variation of human and bovine parainfluenza virus type 3 strains.
    Klippmark E; Rydbeck R; Shibuta H; Norrby E
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1577-80. PubMed ID: 1695673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of hamsters against experimental mumps virus (MuV) infection by antibodies raised against the MuV surface glycoproteins expressed from recombinant vaccinia virus vectors.
    Houard S; Varsanyi TM; Milican F; Norrby E; Bollen A
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():421-3. PubMed ID: 7844562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoproteins of human parainfluenza virus type 3: characterization and evaluation as a subunit vaccine.
    Ray R; Brown VE; Compans RW
    J Infect Dis; 1985 Dec; 152(6):1219-30. PubMed ID: 2999259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge.
    Tao T; Skiadopoulos MH; Durbin AP; Davoodi F; Collins PL; Murphy BR
    Vaccine; 1999 Mar; 17(9-10):1100-8. PubMed ID: 10195620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody prophylaxis and therapy against Nipah virus infection in hamsters.
    Guillaume V; Contamin H; Loth P; Grosjean I; Courbot MC; Deubel V; Buckland R; Wild TF
    J Virol; 2006 Feb; 80(4):1972-8. PubMed ID: 16439553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity.
    Spriggs MK; Murphy BR; Prince GA; Olmsted RA; Collins PL
    J Virol; 1987 Nov; 61(11):3416-23. PubMed ID: 2822951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities.
    van Wyke Coelingh KL; Winter CC; Jorgensen ED; Murphy BR
    J Virol; 1987 May; 61(5):1473-7. PubMed ID: 2437318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization of hamsters with envelope glycoproteins of human parainfluenza virus type 3.
    Ray R; Glaze BJ; Moldoveanu Z; Compans RW
    J Infect Dis; 1988 Apr; 157(4):648-54. PubMed ID: 2831281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of the immunoprotective abilities of glycosylated and deglycosylated parainfluenza virus type 3 surface glycoproteins.
    Ewasyshyn M; Bonneau AM; Usman S; Scollard N; Klein M
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2781-5. PubMed ID: 8277287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic diversity of human parainfluenza virus type 1 isolates and their immunological relationship with Sendai virus revealed by using monoclonal antibodies.
    Komada H; Kusagawa S; Orvell C; Tsurudome M; Nishio M; Bando H; Kawano M; Matsumura H; Norrby E; Ito Y
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():875-84. PubMed ID: 1378879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.